<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://articlefeeds.nasdaq.com/~d/styles/itemcontent.css"?><rss xmlns:a10="http://www.w3.org/2005/Atom" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
  <channel xmlns:nasdaq="http://nasdaq.com/reference/feeds/1.0/">
    <title>Latest Articles about EEA</title>
    <description />
    <language>EN-US</language>
    <lastBuildDate>Wed, 19 Jun 2013 17:44:42 -0400</lastBuildDate>
    <atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://articlefeeds.nasdaq.com/nasdaq/symbols?symbol=EEA" /><feedburner:info uri="nasdaq/symbols" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><item xml:base="http://www.nasdaq.com/article/masimo-wins-a-major-turkish-client-analyst-blog-cm245693">
      <guid isPermaLink="false">245693</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rodK3iC2b68/masimo-wins-a-major-turkish-client-analyst-blog-cm245693</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Masimo Wins a Major Turkish Client - Analyst Blog</title>
      <description>Masimo Corporation  (  MASI  ), a leader in non-invasive monitoring technology, recently revealed that Uludag University Hospital, a renowned healthcare and education institution in Turkey,&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/rodK3iC2b68" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 13 May 2013 23:16:33 Z</pubDate>
      <a10:updated>2013-05-13T21:08:12Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>COV</nasdaq:tickers>
      <nasdaq:tickers>EEA</nasdaq:tickers>
      <nasdaq:tickers>HTWR</nasdaq:tickers>
      <nasdaq:tickers>ISRG</nasdaq:tickers>
      <nasdaq:tickers>MASI</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/masimo-wins-a-major-turkish-client-analyst-blog-cm245693</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/masimo-matches-earnings-est-analyst-blog-cm243422">
      <guid isPermaLink="false">243422</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OWPHr-viXTE/masimo-matches-earnings-est-analyst-blog-cm243422</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Earnings</category>
      <category>Stocks</category>
      <title>Masimo Matches Earnings Est. - Analyst Blog</title>
      <description>Masimo Corporation  (  MASI  ), a leader in non-invasive monitoring technology for patient care, recorded first quarter 2013 earnings per share of 28 cents thereby matching the Zacks Consensus&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/OWPHr-viXTE" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 03 May 2013 17:32:33 Z</pubDate>
      <a10:updated>2013-05-03T14:34:27Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ABMD</nasdaq:tickers>
      <nasdaq:tickers>ARAY</nasdaq:tickers>
      <nasdaq:tickers>COV</nasdaq:tickers>
      <nasdaq:tickers>EEA</nasdaq:tickers>
      <nasdaq:tickers>MAS</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/masimo-matches-earnings-est-analyst-blog-cm243422</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/another-adoption-of-masimo-analyst-blog-cm234730">
      <guid isPermaLink="false">234730</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GdeTJSHIE1g/another-adoption-of-masimo-analyst-blog-cm234730</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Another Adoption of Masimo - Analyst Blog</title>
      <description>Masimo Corporation  (  MASI  ), a leader in non-invasive monitoring technology, recently revealed that the East Tennessee Children???s Hospital has installed Masimo Patient SafetyNet.  This&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/GdeTJSHIE1g" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 08 Apr 2013 23:08:17 Z</pubDate>
      <a10:updated>2013-04-08T21:13:28Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>COV</nasdaq:tickers>
      <nasdaq:tickers>CYBX</nasdaq:tickers>
      <nasdaq:tickers>EEA</nasdaq:tickers>
      <nasdaq:tickers>GIVN</nasdaq:tickers>
      <nasdaq:tickers>MASI</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/another-adoption-of-masimo-analyst-blog-cm234730</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/masimo-expertise-gains-acceptance-analyst-blog-cm232431">
      <guid isPermaLink="false">232431</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_oYqeUU1Mi0/masimo-expertise-gains-acceptance-analyst-blog-cm232431</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Masimo Expertise Gains Acceptance - Analyst Blog</title>
      <description>Masimo Corporation  (  MASI  ), a leader in non-invasive monitoring technology, recently revealed that the well regarded Holland Hospital, serving the Ottawa and Allegan counties of Canada, is&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/_oYqeUU1Mi0" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 01 Apr 2013 23:10:01 Z</pubDate>
      <a10:updated>2013-04-01T20:14:07Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>COV</nasdaq:tickers>
      <nasdaq:tickers>CYBX</nasdaq:tickers>
      <nasdaq:tickers>EEA</nasdaq:tickers>
      <nasdaq:tickers>GIVN</nasdaq:tickers>
      <nasdaq:tickers>MASI</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/masimo-expertise-gains-acceptance-analyst-blog-cm232431</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/masimos-mixed-4q-profit-up-analyst-blog-cm218109">
      <guid isPermaLink="false">218109</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PN6D1mMZ9F8/masimos-mixed-4q-profit-up-analyst-blog-cm218109</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Masimo's Mixed 4Q, Profit Up - Analyst Blog</title>
      <description>Masimo Corporation  (  MASI  ), a leader in non-invasive monitoring technology for patient care, recorded fourth quarter and 2012 earnings per share of 26 cents and $1.04, respectively,&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/PN6D1mMZ9F8" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 15 Feb 2013 18:40:01 Z</pubDate>
      <a10:updated>2013-02-15T14:51:30Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>COV</nasdaq:tickers>
      <nasdaq:tickers>EEA</nasdaq:tickers>
      <nasdaq:tickers>GIVN</nasdaq:tickers>
      <nasdaq:tickers>MASI</nasdaq:tickers>
      <nasdaq:tickers>NVDQ</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/masimos-mixed-4q-profit-up-analyst-blog-cm218109</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/libya-first-to-adopt-pronto7-analyst-blog-cm213830">
      <guid isPermaLink="false">213830</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1004uY4P9gY/libya-first-to-adopt-pronto7-analyst-blog-cm213830</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Libya First to Adopt Pronto-7 - Analyst Blog</title>
      <description>Masimo Corporation  (  MASI  ), a leader in non-invasive monitoring technology, recently revealed that Libya is the first nation to start utilizing the Masimo Pronto-7 to check prospective&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/1004uY4P9gY" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 05 Feb 2013 01:00:01 Z</pubDate>
      <a10:updated>2013-02-04T21:50:57Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>CMN</nasdaq:tickers>
      <nasdaq:tickers>COV</nasdaq:tickers>
      <nasdaq:tickers>CYBX</nasdaq:tickers>
      <nasdaq:tickers>EEA</nasdaq:tickers>
      <nasdaq:tickers>MASI</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/libya-first-to-adopt-pronto7-analyst-blog-cm213830</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/iwk-health-adopts-masimo-knowhow-analyst-blog-cm193883">
      <guid isPermaLink="false">193883</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SkgUfspRuG8/iwk-health-adopts-masimo-knowhow-analyst-blog-cm193883</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>IWK Health Adopts Masimo Know-how - Analyst Blog</title>
      <description>Masimo Corporation  (  MASI  ), a leader in non-invasive monitoring technology for patient care, recently disclosed that IWK Health Centre, a well known Canadian healthcare facility, had&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/SkgUfspRuG8" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 28 Nov 2012 21:40:01 Z</pubDate>
      <a10:updated>2012-11-28T18:40:36Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>COV</nasdaq:tickers>
      <nasdaq:tickers>EEA</nasdaq:tickers>
      <nasdaq:tickers>MASI</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/iwk-health-adopts-masimo-knowhow-analyst-blog-cm193883</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/chmp-positive-on-novartis-drugs-analyst-blog-cm192080">
      <guid isPermaLink="false">192080</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EqYfpIbwOSI/chmp-positive-on-novartis-drugs-analyst-blog-cm192080</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>CHMP Positive on Novartis Drugs - Analyst Blog</title>
      <description>The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recently gave positive opinions on  Novartis  ' (  NVS  ) Bexsero and Exjade (deferasirox).&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/EqYfpIbwOSI" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 22 Nov 2012 02:00:01 Z</pubDate>
      <a10:updated>2012-11-21T22:39:23Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>CHMP</nasdaq:tickers>
      <nasdaq:tickers>EEA</nasdaq:tickers>
      <nasdaq:tickers>NVS</nasdaq:tickers>
      <nasdaq:tickers>PFE</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/chmp-positive-on-novartis-drugs-analyst-blog-cm192080</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/masimo-beefs-up-client-base-analyst-blog-cm191597">
      <guid isPermaLink="false">191597</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sescQ0lpuK8/masimo-beefs-up-client-base-analyst-blog-cm191597</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Masimo Beefs Up Client Base  - Analyst Blog</title>
      <description>Masimo Corporation  (  MASI  ), a leader in non-invasive monitoring technology for patient care, recently disclosed that Maricopa Integrated Health System has set up Masimo Patient SafetyNet.&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/sescQ0lpuK8" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 20 Nov 2012 21:30:01 Z</pubDate>
      <a10:updated>2012-11-20T18:41:45Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>COV</nasdaq:tickers>
      <nasdaq:tickers>EEA</nasdaq:tickers>
      <nasdaq:tickers>MASI</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/masimo-beefs-up-client-base-analyst-blog-cm191597</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/masimos-narrow-miss-on-both-lines-analyst-blog-cm187606">
      <guid isPermaLink="false">187606</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LskV1vsfX7E/masimos-narrow-miss-on-both-lines-analyst-blog-cm187606</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Masimo's Narrow Miss on Both Lines - Analyst Blog</title>
      <description>Masimo Corporation  (  MASI  ), a leader in non-invasive monitoring technology for patient care, reported third quarter 2012 adjusted earnings per share of 24 cents, missing the Zacks&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/LskV1vsfX7E" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 06 Nov 2012 21:40:01 Z</pubDate>
      <a10:updated>2012-11-06T18:49:06Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>COV</nasdaq:tickers>
      <nasdaq:tickers>EEA</nasdaq:tickers>
      <nasdaq:tickers>MASI</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/masimos-narrow-miss-on-both-lines-analyst-blog-cm187606</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/masimo-partners-with-premier-analyst-blog-cm187188">
      <guid isPermaLink="false">187188</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HUuO-jIpZjk/masimo-partners-with-premier-analyst-blog-cm187188</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Masimo Partners with Premier - Analyst Blog</title>
      <description>Masimo Corporation  (  MASI  ), a leader in non-invasive patient monitoring know how, recently revealed that it had inked a deal with Premier, a group purchasing organization, for its SedLine&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/HUuO-jIpZjk" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 05 Nov 2012 22:00:01 Z</pubDate>
      <a10:updated>2012-11-05T18:30:17Z</a10:updated>
      <author>Rajive Mukerji</author>
      <nasdaq:tickers>COV</nasdaq:tickers>
      <nasdaq:tickers>EEA</nasdaq:tickers>
      <nasdaq:tickers>MASI</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/masimo-partners-with-premier-analyst-blog-cm187188</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/masimo-rolls-out-new-product-analyst-blog-cm183942">
      <guid isPermaLink="false">183942</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NSnd2jvDtuA/masimo-rolls-out-new-product-analyst-blog-cm183942</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Masimo Rolls Out New Product - Analyst Blog</title>
      <description>Masimo Corporation  (  MASI  ), a leader in non-invasive patient monitoring technology, recently announced the limited market release of its Universal ReSposable Pulse Oximetry Sensor System.&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/NSnd2jvDtuA" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 24 Oct 2012 01:10:01 Z</pubDate>
      <a10:updated>2012-10-23T22:33:00Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>COV</nasdaq:tickers>
      <nasdaq:tickers>EEA</nasdaq:tickers>
      <nasdaq:tickers>MASI</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/masimo-rolls-out-new-product-analyst-blog-cm183942</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/new-offerings-from-masimo-analyst-blog-cm181633">
      <guid isPermaLink="false">181633</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ccdRfEskqKM/new-offerings-from-masimo-analyst-blog-cm181633</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>New Offerings from Masimo - Analyst Blog</title>
      <description>Recently,  Masimo Corporation  (  MASI  ), a leader in non-invasive patient monitoring technology, announced the European CE Mark approval and introduction of the new fractional arterial oxygen&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/ccdRfEskqKM" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 16 Oct 2012 01:51:29 Z</pubDate>
      <a10:updated>2012-10-16T14:04:32Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>COV</nasdaq:tickers>
      <nasdaq:tickers>EEA</nasdaq:tickers>
      <nasdaq:tickers>MASI</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/new-offerings-from-masimo-analyst-blog-cm181633</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/approval-for-covidiens-nellcor-analyst-blog-cm180576">
      <guid isPermaLink="false">180576</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4JViduGZSKI/approval-for-covidiens-nellcor-analyst-blog-cm180576</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Approval for Covidien's Nellcor - Analyst Blog</title>
      <description>Leading health care products company,  Covidien plc.  (  COV  ) recently won the U.S. Food and Drug Administration (FDA) 510(k) approval as well as the European Economic Area (EEA) CE Mark&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/4JViduGZSKI" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 11 Oct 2012 01:45:01 Z</pubDate>
      <a10:updated>2012-10-10T22:53:04Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>BCR</nasdaq:tickers>
      <nasdaq:tickers>BDX</nasdaq:tickers>
      <nasdaq:tickers>COV</nasdaq:tickers>
      <nasdaq:tickers>EEA</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/approval-for-covidiens-nellcor-analyst-blog-cm180576</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/covidien-launches-nellcor-spo2-analyst-blog-cm150617">
      <guid isPermaLink="false">150617</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oy_fCQPjFj4/covidien-launches-nellcor-spo2-analyst-blog-cm150617</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Covidien Launches Nellcor SpO2 - Analyst Blog</title>
      <description>On June 21,  Covidien plc  (  COV  ), global innovator and manufacturer of healthcare products, announced the launch of Nellcor SpO  2  single parameter module in North America, European Economic&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/oy_fCQPjFj4" height="1" width="1"/&gt;</description>
      <pubDate>Sat, 23 Jun 2012 01:12:12 Z</pubDate>
      <a10:updated>2012-06-22T22:15:42Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>COV</nasdaq:tickers>
      <nasdaq:tickers>EEA</nasdaq:tickers>
      <nasdaq:tickers>PHG</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/covidien-launches-nellcor-spo2-analyst-blog-cm150617</feedburner:origLink></item>
  </channel>
</rss>
